Lisata Therapeutics LSTA
NASDAQ LSTA
$1.47 -0.02 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lisata Therapeutics (LSTA) Gains from Sales and Divestitures (2011 - 2023)

Updated

Lisata Therapeutics (LSTA) recorded Gains from Sales and Divestitures of -$3,000 in FY2023.

Analysis

Lisata Therapeutics (LSTA) Gains from Sales and Divestitures (2011 - 2023) Analysis & Trends

Starting with FY2010, Lisata Therapeutics' Gains from Sales and Divestitures history includes 6 years.

  • The FY2023 figure is the highest annual Gains from Sales and Divestitures since FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Lisata Therapeutics 13.40 Mn 13.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -3,000.00
Sep 30, 2018 50,000.00
Dec 31, 2017 -36,207.00
Dec 31, 2012 -26,617.00
Sep 30, 2011 396,635.00
API Access

Lisata Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LSTA&period=max&api_key=YOUR_API_KEY